Clin Lab. 2022 Aug 1;68(8). doi: 10.7754/Clin.Lab.2021.211138.
Serum ferritin is an acute-phase protein whose level is increased in several inflammatory diseases. This review describes the structure and function of ferritin as well as its association with the prognosis of patients with COVID-19.
We searched MEDLINE/PubMed databases, Scopus, and Web of Science for prospective and review articles that examined ferritin and its association with COVID-19 severity. Based on all these articles and clinical experience, a review was constructed and full texts of the articles that were retrieved were accessed.
All COVID-19 related studies conducted in 2020, which performed serum ferritin testing, clearly showed ferritin as a biomarker of COVID-19 severity in hospitalized patients. Ferritin levels in severe patients were significantly increased relative to those in non-severe patients (p < 0.001). Non-survivors had significantly higher ferritin levels than the survivors (p < 0.001).
Determination of ferritin levels was specific and sensitive for early disease severity prediction in patients with COVID-19. Serum ferritin can also be used for predicting the response to COVID-19 vaccines.
血清铁蛋白是一种急性期蛋白,在几种炎症性疾病中水平升高。本综述描述了铁蛋白的结构和功能及其与 COVID-19 患者预后的关系。
我们检索了 MEDLINE/PubMed 数据库、Scopus 和 Web of Science 中关于铁蛋白及其与 COVID-19 严重程度关系的前瞻性和综述文章。根据所有这些文章和临床经验,构建了一篇综述,并查阅了检索到的文章的全文。
2020 年所有与 COVID-19 相关的研究,对血清铁蛋白进行了检测,明确显示铁蛋白是住院患者 COVID-19 严重程度的生物标志物。与非重症患者相比,重症患者的铁蛋白水平显著升高(p < 0.001)。非幸存者的铁蛋白水平明显高于幸存者(p < 0.001)。
铁蛋白水平的测定对 COVID-19 患者早期疾病严重程度的预测具有特异性和敏感性。血清铁蛋白还可用于预测 COVID-19 疫苗的反应。